Basic information
Biomarker: telomerase
Histology type: endometrial carcinoma
Cohort characteristics
Country: China
Region: Beijing
Followed up time :
Subgroup 1 name : positive
Subgroup 1 number: 28
Subgroup 2 name: negative
Subgroup 2 number: 6
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 40 | EC | 34 | normal endometrial | 6 |
Sample information
Conclusion: Telomerase expression might contribute to the progression of endometrial carcinoma and could be used as its tumor marker.
Sample type : tissue
Sample method: means of telomeric repeat amplification protocol (TRAP) assay
Expression pattern : expression
Disease information
Related information
UniProt Link:
Molecular function from UniProt:
